FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Bioresearch Monitoring Violations at DBC Research

FDA warns Dr. Kevin Bender, doing business as DBC Research in Tamarac, FL, about violations in his conduct of clinical trials.

latest-news-card-1
Human Drugs

Endo Paying $1.5 Billion Fines, Forfeitures

Endo is ordered to pay $1.85 billion in fines and forfeitures after pleading guilty to introducing misbranded Opana ER into interstate commerce and cl...

Medical Devices

LDT Final Rule Legal Challenges Likely: Attorneys

Six Hogan Lovells attorneys comprehensively analyze the new FDA final rule on laboratory-developed tests and predict industry stakeholder litigation c...

latest-news-card-1
FDA General

Hearing to Grill FDA Center Directors

The House Energy and Commerce Committee announces a 5/22 hearing titled Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices, which wil...

latest-news-card-1
Medical Devices

FDA OKs Breakthrough Colorectal Cancer Test

FDA approves Geneoscopys colorectal cancer stool-based screening test ColoSense for those aged 45 years and older with an average risk for developing ...

latest-news-card-1
Biologics

Lilly Gets 6/10 Panel Date for Alzheimers BLA

FDA announces a 6/10 Peripheral and Central Nervous System Drugs Advisory Committee meeting to vote on an Eli Lilly BLA for Alzheimers drug donanemab....

latest-news-card-1
Federal Register

Guide on REMS Logic Model

Federal Register notice: FDA makes available a draft guidance entitled REMS Logic Model: A Framework to Link Program Design With Assessment.

latest-news-card-1
Human Drugs

House Committee Pressures FDA on China Oversight

The House Oversight Committee puts pressure on FDA and its oversight of imported Chinese and other foreign active pharmaceutical ingredients and finis...

latest-news-card-1
FDA General

J&J Reports Favorable TAR-200 Clinical Data

A Phase 2b clinical study evaluating Johnson & Johnsons investigational TAR-200 monotherapy in nonmuscle-invasive bladder cancer patients with carcino...

latest-news-card-1
Human Drugs

GlycoMimetics Phase 3 Leukemia Study Fails

GlycoMimetics says its Phase 3 study of uproleselan plus chemotherapy in acute myeloid leukemia patients did not achieve a statistically significant i...